Lisa von Moltke - 02 Jan 2023 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
Director
Signature
/s/ Darren DeStefano, Attorney-in-Fact
Issuer symbol
CARA
Transactions as of
02 Jan 2023
Net transactions value
$0
Form type
4
Filing time
19 Jan 2023, 16:49:46 UTC
Previous filing
10 Nov 2022
Next filing
07 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARA Stock Option (Right to Buy) Award $0 +45,841 $0.000000 45,841 02 Jan 2023 Common Stock 45,841 $10.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares shall vest and become exercisable in twelve (12) equal quarterly installments beginning on November 1, 2022, in each case subject to the Reporting Person's continued service as of each such date.